Quote:Clinton's lead in the popular vote surpasses 2 million
Fuck trump. It's not over until electors meet on 12/17 and until recounts are done.
If he survives that gauntlet he goes in under a cloud of popular vote deficit and conflicts of interest unprecedented in modern presidential history.
If the EXACT situation pertained to a Clinton electoral vote 'win', Trump and his supporters would be beating the 'rigged election' drum to a deafening beat.
A half-dozen electors, those who will formally cast votes for Trump and Clinton on Dec. 19, are pushing to block Trump from winning a majority of votes.
http://www.politico.com/story/2016/11/clinton...016-231790
By Gabriel Debenedetti, Kyle Cheney and Nolan D. McCaskill
| 11/23/16 06:55 PM EST | Updated 11/23/16 06:53 PM EST
A series of long-shot bids to reconsider the result of the 2016 election cropped up on Wednesday as Democrats and liberals dismayed by Donald Trump’s victory saw Hillary Clinton’s lead in the popular vote surpass 2 million on Wednesday.
Clinton’s camp and leading Democrats have been entirely silent on the efforts — including a potential request for a recount of Pennsylvania, Michigan and Wisconsin sponsored by Green Party candidate Jill Stein — further underscoring the unlikelihood of movement on that front.
But left-leaning activists were nonetheless temporarily cheered after New York Magazine reported on Tuesday evening that Clinton’s campaign chairman John Podesta and campaign attorney Marc Elias spoke with a group of election lawyers and computer scientists about the possibility that results may have been altered in those states.
The former secretary of state has garnered 64,223,958 votes, compared to the president-elect’s 62,206,395, according to a count curated by Dave Wasserman of the nonpartisan Cook Political Report
Trump himself is a noted critic of the Electoral College who called it "a disaster for a democracy” in 2012, and he told New York Times reporters Tuesday he would “rather do the popular vote” and was “never a fan of the Electoral College until now.”
“The popular vote would have been a lot easier,” Trump said, “but it’s a whole different campaign. I would have been in California, I would have been in Texas, Florida and New York, and we wouldn’t have gone anywhere else. Which is, I mean I’d rather do the popular vote.”
“But I think the popular vote would have been easier in a true sense because you’d go to a few places,” he added. “I think that’s the genius of the Electoral College. I was never a fan of the Electoral College until now.”
Clinton's lead in the popular vote surpasses 2 million
Top 10 Most Recent News Articles
Roborock Fuels Market Surge with 27.6% Revenue Boost
Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...
Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies
Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...
Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts
While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...
Continue Reading
Mermaid Folklore Meets Revolution in New Short Film
A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...
Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny
Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...
Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026
Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....
Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation
The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...
Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop
EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...
Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins
An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...
Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization
Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...
Continue ReadingTop 5 Most Recently Viewed Articles
Discover Space-ng's New Computer Vision Solutions
Introducing Space-ng's Innovative Vision System Space-ng is excited to present a revolutionary Hardware Development Kit (HDK) and a Software Development Kit (SDK) tailored for their renowned Sol3 Vision System. This initiative embodies a commitment to affordable, rugged, and air-cooled technology suitable for space applications. The HDK is designed for rapid prototyping,...
Continue Reading
iOnctura Advances Treatment Options for Uveal Melanoma Patients
iOnctura Reports Significant Clinical Progress in Uveal Melanoma iOnctura, a clinical-stage biopharmaceutical company, has recently unveiled critical advancements in its efforts to combat uveal melanoma, a rare form of eye cancer that often presents significant treatment challenges. The company has completed its Phase I DIONE-01 study, showcasing encouraging clinical...
Continue Reading
Spyre Therapeutics Progresses with SPY001 for IBD Treatment
Spyre Therapeutics Reports Encouraging Phase 1 Trial Data Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, has recently released promising interim results from its Phase 1 trial of SPY001, an innovative half-life extended monoclonal antibody aimed at treating inflammatory bowel disease (IBD). The study indicates that SPY001 was well...
Continue Reading
Understanding the University of Phoenix Tuition Guarantee
Understanding the University of Phoenix Tuition Guarantee Fixed tuition and new transparency initiatives support adult learners in planning educational expenses. University of Phoenix is enhancing its commitment to clear and consistent tuition costs through its Tuition Guarantee initiative. This program ensures that students benefit from a locked-in tuition rate from the...
Continue Reading
Halper Sadeh Investigates Shareholder Rights for IPXX, PWUP, DECA, TTNP
Halper Sadeh LLC Investigates Shareholder Rights Halper Sadeh LLC, a law firm dedicated to protecting investor rights, is currently examining several companies for potential violations of federal securities laws and breaches of fiduciary duties. This investigation focuses on significant firms involved in mergers, with the aim of safeguarding shareholder interests....
Continue Reading